Improving Outcomes in Pediatric Congenital Hypothyroidism Through an Electronic Dashboard: A Quality Improvement Initiative
Main Article Content
Abstract
Congenital hypothyroidism (CH) is a prevalent endocrine disorder that can lead to intellectual disability, psychomotor dysfunction, and impaired growth if not treated promptly. Early diagnosis and consistent monitoring are critical, especially during the first three years of life. We developed a PowerBI dashboard integrated with the electronic medical record (EMR) to track thyroid-stimulating hormone (TSH) levels, clinic visits, and upcoming appointments for patients aged 3 months to 3 years. It enables real-time identification of patients not meeting clinical targets, facilitating timely interventions. Prior to dashboard implementation, 75% of patients achieved two or more normal TSH values annually. One year post-implementation, this figure rose to 91%, and further refinements increased it to 93% the following year. The dashboard also improved clinic efficiency by streamlining communication and reducing manual data tracking. This quality improvement (QI) initiative shows the effectiveness of EMR-integrated dashboards in improving clinical outcomes and operational efficiency. The model is scalable and adaptable for other chronic pediatric conditions requiring regular follow-up and laboratory monitoring. Our findings support broader adoption of similar PowerBI dashboards in Endocrinology and other specialties focused on chronic disease management.
Highlights
- Electronic dashboard implementation significantly improved clinical outcomes for pediatric patients with congenital hypothyroidism (CH) at Phoenix Children’s Hospital.
- TSH monitoring compliance increased from 75% to 93% over two years following dashboard deployment.
- The dashboard enabled real-time tracking of lab results, appointments, and patient demographics, streamlining care coordination.
- Quality improvement methodology using Plan-Do-Study-Act (PDSA) cycles facilitated iterative enhancements to the dashboard and clinical workflow.
- The project demonstrates a scalable model for other institutions to improve care for chronic pediatric conditions requiring frequent follow-up and lab monitoring.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Chen, C. Y., Lee, K. T., Lee, C. T., Lai, W. T., & Huang, Y. B. (2013). Epidemiology and clinical characteristics of congenital hypothyroidism in an Asian population: A nationwide population-based study. Journal of Epidemiology, 23(2), 85–94. https://doi.org/10.2188/jea.je20120113
3. Mitchell, M. L., Hsu, H.-W., & Sahai, I. (2011). The increased incidence of congenital hypothyroidism: Fact or fancy? Clinical Endocrinology, 75(6), 806–810. https://doi.org/10.1111/j.1365-2265.2011.04128.x
4. Hinton, C. F., Harris, K. B., Borgfeld, L., et al. (2010). Trends in incidence rates of congenital hypothyroidism related to select demographic factors: Data from the United States, California, Massachusetts, New York, and Texas. Pediatrics, 125(Suppl. 2), S37–S47. https://doi.org/10.1542/peds.2009-1975D
5. Rastogi, M. V., & LaFranchi, S. H. (2010). Congenital hypothyroidism. Orphanet Journal of Rare Diseases, 5(1), 17. https://doi.org/10.1186/1750-1172-5-17
6. Kanike, N., Davis, A., & Shekhawat, P. S. (2017). Transient hypothyroidism in the newborn: To treat or not to treat. Translational Pediatrics, 6(4), 349–358. https://doi.org/10.21037/tp.2017.09.07
7. Rose, S. R., & Brown, R. S. (2006). Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics, 117(6), 2290–2303. https://doi.org/10.1542/peds.2006-0915
8. Arizona Department of Health Services. (2024, May 20). State laboratory services – Newborn screening. https://www.azdhs.gov/preparedness/state-laboratory/newborn-screening/index.php#healthcare-providers-bloodspot
9. Léger, J., Olivieri, A., Donaldson, M., et al. (2014). European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. Hormone Research in Paediatrics, 81(2), 80–103. https://doi.org/10.1159/000358198
10. Büyükgebiz, A. (2013). Newborn screening for congenital hypothyroidism. Journal of Clinical Research in Pediatric Endocrinology, 5(Suppl. 1), 8–12. https://doi.org/10.4274/jcrpe.845
11. Shapira, S. K., Hinton, C. F., Held, P. K., Jones, E., Hannon, W. H., & Ojodu, J. (2015). Single newborn screen or routine second screening for primary congenital hypothyroidism. Molecular Genetics and Metabolism, 116(3), 125–132. https://doi.org/10.1016/j.ymgme.2015.08.003
12. Murphy, N., Hume, R., van Toor, H., et al. (2004). The hypothalamic-pituitary-thyroid axis in preterm infants: Changes in the first 24 hours of postnatal life. The Journal of Clinical Endocrinology & Metabolism, 89(6), 2824–2831. https://doi.org/10.1210/jc.2003-030317
13. Jonklaas, J., Bianco, A. C., Bauer, A. J., et al. (2014). Guidelines for the treatment of hypothyroidism: Prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid, 24(12), 1670–1751. https://doi.org/10.1089/thy.2014.0028
14. Bongers-Schokking, J. J., Koot, H. M., Wiersma, D., Verkerk, P. H., & de Muinck Keizer-Schrama, S. M. (2000). Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. Journal of Pediatrics, 136(3), 292–297. https://doi.org/10.1067/mpd.2000.103351
15. Stagi, S., Municchi, G., Ferrari, M., & Wasniewska, M. G. (2022). An overview on different L-thyroxine (L-T4) formulations and factors potentially influencing the treatment of congenital hypothyroidism during the first 3 years of life. Frontiers in Endocrinology, 13, Article 859487. https://doi.org/10.3389/fendo.2022.859487
16. Sandblom, L., Kapadia, C., Vaidya, V., et al. (2023). Electronic dashboard to improve outcomes in pediatric patients with type 1 diabetes mellitus. Journal of Diabetes Science and Technology. Advance online publication. https://doi.org/10.1177/19322968231159401
17. Klosinska, M., Kaczynska, A., & Ben-Skowronek, I. (2022). Congenital hypothyroidism in preterm newborns – The challenges of diagnostics and treatment: A review. Frontiers in Endocrinology, 13, Article 860862. https://doi.org/10.3389/fendo.2022.860862
18. Esposito, A., Vigone, M. C., Polizzi, M., Wasniewska, M. G., Cassio, A., Mussa, A., Gastaldi, R., Di Mase, R., Vincenzi, G., Pozzi, C., Peroni, E., Bravaccio, C., Capalbo, D., Bruzzese, D., & Salerno, M. (2022). Effect of initial levothyroxine dose on neurodevelopmental and growth outcomes in children with congenital hypothyroidism. Frontiers in Endocrinology, 13, Article 923448. https://doi.org/10.3389/fendo.2022.923448
19. Uchida, K., & Suzuki, M. (2021). Congenital hypothyroidism and brain development: Association with other psychiatric disorders. Frontiers in Neuroscience, 15, Article 772382. https://doi.org/10.3389/fnins.2021.772382